Leishmaniasis, Cutaneous: all 110 studies
Page 1 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in PakistanNot yet recruitingNCT07858357Not applicable
- Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With LeishmaniasisRecruitingNCT07783243
- Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health WorkersNot yet recruitingNCT07506967Not applicable
- LEISH-PED: Study on Leishmaniasis in ChildrenRecruitingNCT07504757
- Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)Not yet recruitingNCT07463040Phase 3
- Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous LeishmaniasisNot yet recruitingNCT07149753Phase 1
- Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.RecruitingNCT06822478Phase 3
- Intralesional Injection of Metronidazole for the Management of Cutaneous LeishmaniasisRecruitingNCT06798415Phase 2
- Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium StibogluconateRecruitingNCT06798402Phase 2
- Intralesional Injection of Levofloxacin for the Management of Cutaneous LeishmaniasisRecruitingNCT06797544Phase 2
- Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care SetupRecruitingNCT06746350Not applicable
- Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in EthiopiaNot yet recruitingNCT06695143Phase 3
- OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis PatientsRecruitingNCT06514560
- Tofacitinib Associated With Meglumine Antimoniate in Cutaneous LeishmaniasisNot yet recruitingNCT06011343Phase 2/3
- Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous LeishmaniasisRecruitingNCT05708625Phase 3
- Pilot Study Using a Heat Pack to Treat Cutaneous LeishmaniasisAvailableNCT01277796
- Diagnosis and Treatment of Leishmania InfectionsRecruitingNCT00344188
- Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in PanamaCompletedNCT01790659Phase 3Results posted
- Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in TunisiaCompletedNCT01769612Results posted
- A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous LeishmaniasisCompletedNCT01536795Phase 2Results posted
- WR 279,396 Open Label Treatment Protocol in TunisiaTerminatedNCT01494350Phase 2Results posted
- Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous LeishmaniasisTerminatedNCT01140191Phase 2Results posted
- Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in PanamaCompletedNCT01083576Phase 2Results posted
- Miltefosine to Treat Mucocutaneous LeishmaniasisCompletedNCT01050907Phase 2Results posted
- Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)CompletedNCT01032382Phase 2Results posted
- A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous LeishmaniasisCompletedNCT01011309Phase 2Results posted
- Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous LeishmaniasisCompletedNCT00884377Phase 2Results posted
- Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old WorldCompletedNCT00703924Phase 2Results posted
- Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396TerminatedNCT00657917Phase 2Results posted
- Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test AntigenCompletedNCT00633009Phase 2Results posted
- Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)CompletedNCT00606580Phase 3Results posted
- Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.CompletedNCT00471705Phase 3Results posted
- Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East SyriaCompletedNCT06917040Phase 3
- Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the DiseaseCompletedNCT06692985
- Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the ElderlyCompletedNCT06449040Phase 1/2
- Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.CompletedNCT06000514Phase 1/2
- Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in ColombiaCompletedNCT05533736Not applicable
- Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective StudyStatus unknownNCT05493059
- Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in EthiopiaCompletedNCT05332093
- Arnica Tincture Fot the Treatment of Cutaneous LeishmaniasisActive, not recruitingNCT05094908Phase 1
- Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH)CompletedNCT04888130
- Development of Topical Herbal Formulations for Treatment of Cutaneous LeishmaniasisCompletedNCT04841239Not applicable
- Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in EthiopiaCompletedNCT04699383
- Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New WorldCompletedNCT04515186Phase 3
- A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand FliesCompletedNCT04512742Not applicable
- Performance of RPA-LF for Cutaneous LeishmaniasisCompletedNCT04500873
- Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)CompletedNCT04340128Phase 3
- Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in PakistanCompletedNCT04268524Phase 3
- Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.WithdrawnNCT04072874Phase 1/2
- Outcomes of Complicated CL in Ethiopia Treated With MiltefosineCompletedNCT04004754
- Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in BelgiumTerminatedNCT04001335
- A Clinical Study to Develop an Uninfected Sand Fly Biting ProtocolCompletedNCT03999970Not applicable
- A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDLCompletedNCT03969134Phase 2
- Single Oral Dose Escalation Study of DNDI-0690 in Healthy SubjectsCompletedNCT03929016Phase 1
- Cutaneous Leishmaniasis Diagnostic StudyCompletedNCT03837431
- Oral Miltefosine Plus Topical Paromomycin In American Cutaneous LeishmaniasisCompletedNCT03829917Phase 2/3
- Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in PeruStatus unknownNCT03762070
- Miltefosine Plus IL Pentamidine for Bolivian CLCompletedNCT03445897Phase 2
- Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in AfghanistanCompletedNCT03435419
- ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -CompletedNCT03303898Not applicable
- Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous LeishmaniasisCompletedNCT03294161Phase 2
- Complex Cutaneous Leishmaniasis Healing Study in AlgeriaTerminatedNCT03292835
- Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, PakistanTerminatedNCT03208543Phase 3
- Topical Paromomycin for Cutaneous Leishmaniasis in BoliviaCompletedNCT03096457Phase 2/3
- Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis PatientsStatus unknownNCT03084952Phase 2
- Miltefosine and GM-CSF in Cutaneous LeishmaniasisCompletedNCT03023111Phase 3
- Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in MoroccoCompletedNCT02979002
- Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. GuyanensisCompletedNCT02919605Phase 2
- A Study of a New Leishmania Vaccine Candidate ChAd63-KHCompletedNCT02894008Phase 2
- Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨CompletedNCT02687971Phase 2
- Topical Liposomal Amphotericin B Gel Treatment for Cutaneous LeishmaniasisCompletedNCT02656797Phase 2
- The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in BrazilActive, not recruitingNCT02530697Phase 2
- Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli PatientsStatus unknownNCT02281669
- WR 279,396 for the Treatment of Cutaneous LeishmaniasisCompletedNCT01988909Phase 2
- High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and ManausTerminatedNCT01953744Phase 3
- Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in ColombiaCompletedNCT01845727Phase 1/2
- Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in IndiaCompletedNCT01661296Phase 4
- Paromomycin for Individuals With Uncomplicated Cutaneous LeishmaniasisNo longer availableNCT01641796
- Add-on Study of Pentoxifylline in Cutaneous LeishmaniasisCompletedNCT01464242Phase 2/3
- Pharmacokinetics of Miltefosine in Children and AdultsCompletedNCT01462500Phase 4
- Antimony Plus Pentoxifylline in Cutaneous LeishmaniasisCompletedNCT01381055Phase 2/3
- Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous LeishmaniasisCompletedNCT01380314Phase 2
- Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and AntimonyTerminatedNCT01380301Phase 2
- Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous LeishmaniasisCompletedNCT01301924Phase 2/3
- Intralesional Antimony for Bolivian Cutaneous LeishmaniasisCompletedNCT01300975Phase 2
- Efficacy of Topical Liposomal Form of Drugs in Cutaneous LeishmaniasisCompletedNCT01050777Early Phase 1
- Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis PatientsCompletedNCT00996463Phase 2
- Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous LeishmaniasisCompletedNCT00973128Phase 2
- Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous LeishmaniasisStatus unknownNCT00840359Phase 2
- Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age PatientsCompletedNCT00818818Phase 4
- Frequency of Parasite Infection in Hyraxes and Sandflies During Outbreak of Leishmania Tropica Epidemic in The West BankStatus unknownNCT00737386
- Safety and Efficacy of Azithromycin to Treat Cutaneous LeishmaniasisTerminatedNCT00682656Phase 2/3
- Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)CompletedNCT00600548Phase 2
- Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in BoliviaStatus unknownNCT00537953Phase 2
- Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World LeishmaniasisNo longer availableNCT00508963
- Cosmetic Outcome of Leishmaniasis Scar After WR279396 ApplicationCompletedNCT00490230Not applicable
- Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in ColombiaStatus unknownNCT00487253Phase 3
- Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and AllopurinolCompletedNCT00480883Not applicable
- Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous LeishmaniasisCompletedNCT00469495Not applicable
- Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. TropicaCompletedNCT00351520Phase 3